Global Microcarrier Market Size, Share, Opportunities, And Trends By Product Type (Equipment, Consumables, Reagents, Microcarrier Beads, Others), By Application (Biopharmaceutical Production, Cell And Gene Therapy, Others), By End Users (Pharmaceutical & Biotechnology Companies, Research Institutes, Contract Research Organizations), And By Geography - Forecasts From 2025 To 2030

The microcarrier market is projected to grow at a CAGR of 9.32% during the forecast period to reach US$1,905.292 million by 2030, up from US$1,548.099 million in 2025.

Microcarriers are microscopic beads or spheres used to increase the surface area in tissue culture for the attachment and yield of anchorage-dependent cells and act as a support matrix, which allows the growth of adherent cells in bioreactors. Microcarriers are extensively used in the large-scale commercial production of biologics and vaccines to grow virus-generating or protein-producing adherent cell populations. The growth in the microcarriers market may be attributed to the rapid growth in the biologics and biosimilar industries.

Rising demand for cell-based vaccines, along with technological advancements, will positively impact the market for microcarriers. However, the high cost of cell biologics and cell-based therapies might hamper the market growth during the given forecast period. Growth limitations of high-density microcarrier cultures will also restrain the microcarrier’s market growth during the anticipated period. Further, the microcarrier market is segmented into product, application, end-user, and geography.  

Market Drivers:

• The Microcarriers market will grow due to the rising demand for cell-based vaccines.

Due to the growing number of new virus outbreaks such as influenza, monkeypox, Ebola, and COVID-19, among others, the demand for vaccines is increasing globally, consequently increasing the demand for microcarriers in the market and supporting the microcarrier market growth during the forecast period. For instance, the World Health Organization’s Disease Outbreak News (DONs), which provided confirmed acute public health events of potential events of concern, reported an Ebola virus outbreak in the Democratic Republic of the Congo in September 2022.

The Ministry of Health of the Democratic Republic of the Congo declared the outbreak following the confirmed laboratory test via RT-PCR in a fatal case in Beni Health Zone, North Kivu Province. During the same period, Uganda also witnessed a confirmed 18 cases as of 25th September 2022 Ebola virus, which were caused by the Sudan Virus. Such increasing cases of infectious diseases and the growing risk of pandemics are the prime factors driving the demand for vaccines worldwide. Further, many organizations are putting efforts into developing vaccines for the rising disease. For instance, the Centers for Disease Control and Prevention (CDC) mentions in its Vaccine Considerations summary, updated in September 2022, that the JYNNEOS vaccine is approved for the prevention of monkeypox and smallpox diseases.

Further, the ACAM2000 Vaccines has been approved for immunization against smallpox which is made available for use against monkeypox under Expanded Access Investigational New Drug protocol, mentions the CDC.   The microcarrier market is expected to be dominated by the North American region, which is expected to hold a significant share of the Microcarrier market. The rising research and development activities, gene therapies, and biologics, coupled with technological advancement and investment in cell-based research in countries like the US.  

Additionally, the prevalence of established pharmaceutical companies, who continually work to expand their geographic reach and promote the widespread marketing of their vaccines, is anticipated to spur market expansion in this region. Moreover, this region will grow due to the increased need for immunizations during pandemics. due to the rise in the prevalence of infectious and cancerous illnesses.

On the other hand, Europe holds the second largest share of the microcarrier market during the anticipated period owing to the increasing number of leading firms in the market and growing usage of technical innovations. It is anticipated that increased R&D utilization will enhance product development and market demand in this region.

Key Developments:

• November 2024: Rousselot and IamFluidics launched an innovative, dissolvable microcarrier that revolutionizes scalable cell culturing. The product dissolves within 15 minutes of contacting standard cell culture reagents, enabling cells to be harvested efficiently with over 90% viability. The IamFluidics' patented IN-AIR MICROFLUIDICS technology is used in the manufacture of the dissolvable microcarrier. These are alginate-based microcarriers, Rousselot's denatured collagen, which comes with full documentation and a virus-inactivation certificate.

 

• October 2024: Cellevate pre-launched its innovative nanofiber microcarriers for viral vector manufacturing at CPHI Milan. These first-of-type microcarriers, branded as Cellevat3d, gave a surface area of up to 60 times more than the traditional systems for cell growth. They were designed for stirred-tank bioreactors, where they improved the productivity and yield of gene therapy applications. An attempt was made to address the problems with viral vector production to make available treatments for more patients.

Company Products:

• SoloHill® Microcarrier Starter Kit- Sartorius AG's SoloHill® Microcarrier Starter Kit is a 10-gram kit containing six different types of SoloHill® microcarriers, both protein-coated and non-coated, for specific cell types. This low-cost solution accelerates microcarrier evaluation, allowing for the selection of the optimal microcarrier type for specific applications, ensuring optimal cell attachment and growth.
• HarvestainerTM Microcarrier Separation system- Thermo Fisher Scientific offers the HarvestainerTM Microcarrier Separation system, which is an ideal solution for the separation of microcarrier beads during adherent cell culture production. It is an ideal system for smaller-scale as well as larger-scale applications for in-line microcarrier separation. In comparison to conventional procedures, the system helps to boost product yields while lowering the need for clean-in-place, steam-in-place, and water for injection.
• Corning® Microcarriers- Corning incorporated offers Corning® Microcarriers for Bioprocess scale-up that are designed to simplify the scale-up processes. The microcarriers are provided in closed systems packaging, are sterile, and are prepared for use with bioreactors. The microcarriers are additionally surface-treated to improve cell adhesion and increase cell production and survival.

Microcarrier Market Scope:

Report Metric	Details
Market Size Value in 2025	US$1,548.099 million
Market Size Value in 2030	US$1,905.292 million
Growth Rate	CAGR of 9.32%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Million
Segments Covered	Product Type Application End-Users Geography
Companies Covered	Thermo Fisher Scientific Corning Incorporated Sartorius AG Pall Corporation Batavia Biosciences B.V.
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Customization Scope	Free report customization with purchase

Market Segments:

• By Product Type
  • Equipment
  • Consumables
  • Reagents
  • Microcarrier Beads
  • Others
• By Application
  • Biopharmaceutical Production
  • Cell and gene therapy
  • Others
• By End-Users
  • Pharmaceuticals & Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL MICROCARRIERS MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Equipment

5.2.1. Market Opportunities and Trends

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Consumables

5.3.1. Market Opportunities and Trends

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

5.4. Reagents

5.4.1. Market Opportunities and Trends

5.4.2. Growth Prospects

5.4.3. Geographic Lucrativeness

5.5. Microcarrier Beads

5.5.1. Market Opportunities and Trends

5.5.2. Growth Prospects

5.5.3. Geographic Lucrativeness

5.6. Others

5.6.1. Market Opportunities and Trends

5.6.2. Growth Prospects

5.6.3. Geographic Lucrativeness

6. GLOBAL MICROCARRIERS MARKET BY APPLICATION

6.1. Introduction

6.2. Biopharmaceutical Production

6.2.1. Market Opportunities and Trends

6.2.2. Growth Prospects

6.2.3. Geographic Lucrativeness

6.3. Cell and gene therapy

6.3.1. Market Opportunities and Trends

6.3.2. Growth Prospects

6.3.3. Geographic Lucrativeness

6.4. Others

6.4.1. Market Opportunities and Trends

6.4.2. Growth Prospects

6.4.3. Geographic Lucrativeness

7. GLOBAL MICROCARRIERS MARKET BY END-USERS

7.1. Introduction

7.2. Pharmaceuticals & Biotechnology Companies

7.2.1. Market Opportunities and Trends

7.2.2. Growth Prospects

7.2.3. Geographic Lucrativeness

7.3. Research Institutes

7.3.1. Market Opportunities and Trends

7.3.2. Growth Prospects

7.3.3. Geographic Lucrativeness

7.4. Contract Research Organizations

7.4.1. Market Opportunities and Trends

7.4.2. Growth Prospects

7.4.3. Geographic Lucrativeness

8. GLOBAL MICROCARRIERS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Product Type

8.2.2. By Application

8.2.3. By End Users

8.2.4. By Country

8.2.4.1. USA

8.2.4.1.1. Market Opportunities and Trends

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Opportunities and Trends

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Opportunities and Trends

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Product Type

8.3.2. By Application

8.3.3. By End Users

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Opportunities and Trends

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Opportunities and Trends

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Opportunities and Trends

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Product Type

8.4.2. By Application

8.4.3. By End Users

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Opportunities and Trends

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Opportunities and Trends

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Opportunities and Trends

8.4.4.3.2. Growth Prospects

8.4.4.4. Spain

8.4.4.4.1. Market Opportunities and Trends

8.4.4.4.2. Growth Prospects

8.4.4.5. Others

8.4.4.5.1. Market Opportunities and Trends

8.4.4.5.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Product Type

8.5.2. By Application

8.5.3. By End Users

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Opportunities and Trends

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Opportunities and Trends

8.5.4.2.2. Growth Prospects

8.5.4.3. Israel 

8.5.4.3.1. Market Opportunities and Trends

8.5.4.3.2. Growth Prospects

8.5.4.4. Others

8.5.4.4.1. Market Opportunities and Trends

8.5.4.4.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Product Type

8.6.2. By Application

8.6.3. By End Users

8.6.4. By Country

8.6.4.1. China

8.6.4.1.1. Market Opportunities and Trends

8.6.4.1.2. Growth Prospects

8.6.4.2. India

8.6.4.2.1. Market Opportunities and Trends

8.6.4.2.2. Growth Prospects

8.6.4.3. Japan

8.6.4.3.1. Market Opportunities and Trends

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Opportunities and Trends

8.6.4.4.2. Growth Prospects

8.6.4.5. Indonesia

8.6.4.5.1. Market Opportunities and Trends

8.6.4.5.2. Growth Prospects

8.6.4.6. Others

8.6.4.6.1. Market Opportunities and Trends

8.6.4.6.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Thermo Fisher Scientific

10.2. Corning Incorporated

10.3. Sartorius AG

10.4. Pall Corporation

10.5. Batavia Biosciences B.V.

10.6. Primorigen Biosciences

10.7. Cytiva

10.8. Nucleus Biologics, LLC.

10.9. Merck KGaA

10.10. Entegris

Thermo Fisher Scientific

Corning Incorporated

Sartorius AG

Pall Corporation

Batavia Biosciences B.V.

Primorigen Biosciences

Cytiva

Nucleus Biologics, LLC.

Merck KGaA

Entegris